Variables | Unadjusted analysis | Adjusted analysis | ||
---|---|---|---|---|
OR (95% CI) | P value | OR (95% CI) | P value | |
Age | 1.00 (0.97–1.03) | 0.99 | 1.01 (0.97–1.06) | 0.56 |
Disease durationa | 2.28 (0.93–5.59) | 0.07 | 1.81 (0.48–6.85) | 0.39 |
BMI | 1.08 (0.97–1.20) | 0.15 | 1.07 (0.93–1.24) | 0.34 |
DAS28-ESRb | 10.5 (3.40–32.1) | <0.05 | 6.88 (1.84–25.7) | <0.05 |
RF positive | 2.39 (0.64–8.94) | 0.19 | 1.82 (0.40–8.37) | 0.44 |
Glucocorticoid | 4.59 (1.48–14.2) | <0.05 | 8.24 (1.77–38.4) | <0.05 |
Biologic DMARDs | 4.21 (1.86–9.51) | <0.05 | 1.89 (0.54–6.64) | 0.32 |
RA involvement | ||||
Forefoot | 0.72 (0.30–1.75) | 0.47 | 0.85 (0.28–2.60) | 0.77 |
Midfoot | 6.00 (2.28–15.8) | <0.05 | 5.81 (1.41–23.9) | <0.05 |
Hindfoot | 2.85 (1.30–6.25) | <0.05 | 1.24 (0.41–3.76) | 0.71 |
Ankle | 0.66 (0.07–6.54) | 0.72 | 0.29 (0.02–5.73) | 0.42 |
Foot deformity | ||||
Hallux valgus | 1.33 (0.54–3.28) | 0.53 | 0.68 (0.19–2.51) | 0.56 |
Metatarsus primus varus | 0.89 (0.39–2.03) | 0.78 | 0.93 (0.30–2.85) | 0.90 |
Pes planus | 1.00 (0.18–5.71) | 1.00 | 0.50 (0.05–5.22) | 0.56 |